Research progress in anticancer drugs of the metallic complexes and their pharmacological effect

Chinese Pharmacological Bulletin

Volumn 23, Issue 11, 2007, Pages 1409-1413

  Mu, Yong Ping ^a   Wu, Gang ^a   Zhou, Li She ^a   He, Yan Ling ^a  

^a BAOTOU MEDICAL COLLEGE   (China)

Author keywords

Anticancer; Complexes; Metal

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; METAL COMPLEX; NEDAPLATIN; OXALIPLATIN; PLATINUM COMPLEX; SATRAPLATIN;

ANTINEOPLASTIC ACTIVITY; COMPLEX FORMATION; DRUG MECHANISM; DRUG RESEARCH; REVIEW;

EID: 38349129973     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Wong E, Giandomenico C M. Current status of platinum-based antitumor drugs[J]. Chem Rev,1999,99(9):2451-66.
2. Wu K, Meng G, Wang Y, Zhou Q. Relationships between induction of apoptosis by CDDP in Scaber ceil and apoptosis-related proteins[J]. Chin Pharmacol Bull,2003,19(10):1143-7.
3. Liao Y J, Tan G H, Jin Y P. Study of toxic effects on hearing, kidney and liver of mice induced by anticancer agent of cis-platin and their mechanisms[J]. Chin Pharmacol Bull,2004,20(1):82-5.
4. Perez J M, Fuertes M A, Alonso C, et al. Current status of the development of trans plantinum antitumor drugs[J]. Crit Rev Oncol Hematol,2000,35:109-20.
5. McKeage MJ. Lobaplatin: a new antitumor platinum drug[J]. Expert Opin Investig Drugs,2001,10(1):119-28.
6. Perego P, Caserini C, Gatti L, et al. A novel trinuclear platinum complexes overcomes eisplatin resistance in an osteosarcoma cell system[J]. Mol Pharmcol,1999,55(3):528-34.
7. Perez J M, Camazon M, Alvarez-Valdes A, et al. Synthesis, characterization and DNA modification induced by a novel Pt (IV)-bis (monoglutarate) complex which induces apoptosis in glioma cells[J]. Chem Biol Interact,1999,117(2):99-115.
8. Bai X Y, Ma Y X, Zhou Y, et al. The effect of recombinant-adenovirus mediated p53 gene transfer on KB cell apoptosis induced by cisplatin[J]. Chin Pharmacol Bull,2001,17(3):278-81.
9. Liu X Y, Liu L S, Wang H C, Wang C Y. Synthesis and antineoplastic activity evaluations of platinum(IV) complexes[J]. Chin J Med Chem,2002,12(5):272-45.
10. 2[J]. Precious Metals,2004, 25(2):20-3.
11. Zhang J, Sun R G, Qi H. Physic-chemical characteristics of the platosammine fatty acids and effects of magnetic field on tumor cells[J]. Acta Photon Sin,2002,31(12):1458-61.
12. Yang M, Xiao S L, Zhou T Y, et al. Molecular recognition of two binding modes of DNA with novel chiral Pt complexes[J]. J Beijing Med Univ,2000,32(3):198-202.
13. Gao Y X, Li R C, Wu G, et al. Studies on the chiral selectivity of transmembrane transport of the Pt(II) complexes with 1,2-Diaminocydohexane as carrier ligand into human erythrocytes[J]. Acta Chim Sin,1999, 57(7):659-66.
14. Qiao X W, Wu G, Li R C, et al. Studies on the structures of Pt (IV) anticancer complexes and the kinetics and mechanism of ther cellular uptake[J]. Chin Pharm J,2004,39(4):292-5.
15. Wang Z M, Ji L N. Progress of ruthenium-based antitumor complexes[J]. Prog Chem,2002,14(4):296-304.
16. Mishra L, Sinha R, Itokawa H, et al. Anti-HIV and cytotoxic activities of Ru(II)/Ru(III) polypyridyl complexes containing 2,6-(2′-benzimidazolyl)- pyridine/chalcone as co-ligand[J]. Bioorg Med Chem,2001,9:1667-71.
17. 2(mu-L)] (L = ditopic, non-chelating aromatic N-ligand). A preliminary investigation[J]. J Inorg Biochem,2000,79(1-4):173-7.
18. Sava G, Bergamo A, Zorzet S, et al. Influence of chemical stability on the activity of the antimetastasis ruthenium compound NAMI-A[J]. Eur J Cancer,2002,38(3):427-35.
19. Liu J, Ji L G, Mei W J. The Development of ruthenium complexes as anticancer drugs activation and anticancer mechanism[J]. Prog Chem,2004,16(6):969-73.
20. Mei W J, Liu J, Li A X, et al. Investigation on the interaction of ruthenated porphyria [Ru(bpy)2(MPyTPP)Cl] with Calf Thymus DNA[J]. Chem Res Chin Univ,2002,23(11):2049-51.
21. Sava G, Alessio E, Bergamo A, et al. Tumor metrastase sulfoxide ruthenium complexes: non-toxic tools for the selective treatment of solids[J]. Topics Biol Inorg chem,1999,8:143-69.
22. Trynda-Lemiesz L, Keppler B K, Kozlowski H. Studies on the interactions between human serum albumin and imidazolium [trans-tetrachlorobis (imidazol) ruthenate (II)][J]. Inorg-Biochem, 1999,73:123-8.
23. Yin F L, She J, Zou J J, Li R C. Study on the synthesis, characterization, crystal structure and anticancer acitivity of a bridging ligand complex of cu(II) with 2,2′-bipyridine and demethylcantharate.[J]. Acta Chim Sin,2003,61(4):556-61.
24. Zhao X R, Mo J. Study on the copper complexes of p-cholro p-methoxyacetophenone thiosemicar-bazone and their anticancer activities[J]. Pharm J Chin People's Liber Army,2001,17(3):137-9.
25. Li X B, Zhou A R, Yu W H, Chen X G. Effect of lanthanum citrate on two cell lines: human lung cancer cells PG and human gastric carcinoma cells BGC-823[J]. J Chin Rare Earth Soc,2000,18(2):156-69.